Amelia McCartney

1.5k total citations · 1 hit paper
44 papers, 856 citations indexed

About

Amelia McCartney is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Amelia McCartney has authored 44 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Amelia McCartney's work include Advanced Breast Cancer Therapies (22 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (11 papers). Amelia McCartney is often cited by papers focused on Advanced Breast Cancer Therapies (22 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (11 papers). Amelia McCartney collaborates with scholars based in Italy, Australia and United States. Amelia McCartney's co-authors include Angelo Di Leo, Laura Biganzoli, Luca Malorni, Ilenia Migliaccio, Matteo Benelli, Leonardo Tenori, Claudio Luchinat, Irene De Santo, Emanuela Risi and Alessia Vignoli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Amelia McCartney

39 papers receiving 845 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)

2021 157 citations Laura Biganzoli, Amelia McCartney et al. profile →

Peers

Countries citing papers authored by Amelia McCartney

Since Specialization

Citations

This map shows the geographic impact of Amelia McCartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia McCartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia McCartney more than expected).

Fields of papers citing papers by Amelia McCartney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia McCartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia McCartney. The network helps show where Amelia McCartney may publish in the future.

Co-authorship network of co-authors of Amelia McCartney

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia McCartney. A scholar is included among the top collaborators of Amelia McCartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia McCartney. Amelia McCartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effectiveness of structured physical activity on agitation in people with dementia: a rapid review 2024 ·Aging & Mental Health ·Amelia McCartney, (unknown), Snorri Björn Rafnsson, Juanita Hoe	1
2	Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study 2024 ·The Breast ·(unknown), (unknown), (unknown), Kim Cao, Daphne Day, Katie N. Evans, (unknown), Gwo‐Yaw Ho, (unknown), Amelia McCartney, (unknown), Ranjana Srivastava, (unknown), (unknown), Kate Webber, Michelle White, Steven David, Marion Harris	0
3	Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model 2023 ·Vaccines ·Tammie Choi, Bryan Chan, Lisa Grech, Alastair Kwok, Kate Webber, (unknown), (unknown), (unknown), Daphne Day, Amelia McCartney, (unknown), Eva Segelov, (unknown)	4
4	European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care 2023 ·European Journal of Cancer ·Fátima Cardoso, Amelia McCartney, Antonio Ponti, Lorenza Marotti, Conny Vrieling, Alexandru Eniu, Berta Sousa, Carla Ripamonti, Luzia Travado, (unknown), (unknown), Giuseppe Curigliano, Frédérique Penault‐Llorca, Frédéric Lecouvet, Isabel T. Rubio, Laura Biganzoli	7
5	250TiP HER2-positive and HER2-low breast cancer patients in the ACE-Pan tumor-01 study: Phase I study evaluating ARX788 as monotherapy in advanced solid tumors with HER2 expression or mutation 2022 ·Annals of Oncology ·Jianqin Lu, G. T. Budd, Sophia Frentzas, (unknown), Catherine Shannon, H. S. Rugo, Joyce O’Shaughnessy, A. DeMichele, Sara M. Tolaney, (unknown), Amelia McCartney, Katharine Cuff, (unknown), (unknown), (unknown), (unknown), Tiep Le, (unknown), (unknown), (unknown)	1
6	Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer 2021 ·International Journal of Molecular Sciences ·Alessia Vignoli, Emanuela Risi, Amelia McCartney, Ilenia Migliaccio, Erica Moretti, Luca Malorni, Claudio Luchinat, Laura Biganzoli, Leonardo Tenori	28
7	Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial 2021 ·Breast Cancer Research ·Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro Marco Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, (unknown), Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni	25
8	A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting 2021 ·Cancers ·Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, (unknown), (unknown), (unknown), Ilenia Migliaccio, Stefano Cantafio, (unknown), (unknown), (unknown), Francesca Del Monte, (unknown), Amelia McCartney, Angelo Di Leo, Claudio Luchinat, Laura Biganzoli	17
9	Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial 2020 ·Clinical Cancer Research ·Amelia McCartney, Martina Bonechi, Francesca De Luca, Chiara Biagioni, Giuseppe Curigliano, Erica Moretti, Alessandro Marco Minisini, Mattias Bergqvist, Matteo Benelli, Ilenia Migliaccio, Francesca Galardi, Emanuela Risi, Irene De Santo, Dario Romagnoli, Laura Biganzoli, Angelo Di Leo, Luca Malorni	37
10	Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer 2020 ·Cancers ·Veronica Ghini, Letizia Laera, (unknown), Francesca Del Monte, Matteo Benelli, Amelia McCartney, Leonardo Tenori, Claudio Luchinat, Daniele Pozzessere	74
11	CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer 2020 ·Cancer Treatment Reviews ·Ilenia Migliaccio, Martina Bonechi, Amelia McCartney, Cristina Guarducci, Matteo Benelli, Laura Biganzoli, Angelo Di Leo, Luca Malorni	21
12	Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors 2020 ·British Journal of Cancer ·Amelia McCartney, Luca Malorni	5
13	Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center 2020 ·SHILAP Revista de lepidopterología ·(unknown), Katrina Hueniken, (unknown), Lu Lu, (unknown), (unknown), Amelia McCartney, Yu Gao, Muh‐Lii Liang, (unknown), (unknown), (unknown), (unknown), (unknown), Liu G	3
14	Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification 2019 ·npj Breast Cancer ·Amelia McCartney, Alessia Vignoli, Leonardo Tenori, Monica Fornier, Lorenzo Rossi, Emanuela Risi, Claudio Luchinat, Laura Biganzoli, Angelo Di Leo	14
15	Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial 2019 ·Breast Cancer Research ·Lorenzo Rossi, Chiara Biagioni, Amelia McCartney, Ilenia Migliaccio, Giuseppe Curigliano, Giuseppina Sanna, Erica Moretti, Alessandro Marco Minisini, Saverio Cinieri, Carlo Tondini, Grazia Arpino, Antônio Bernardo, Angelo Martignetti, Emanuela Risi, Marta Pestrin, Luca Boni, Matteo Benelli, Laura Biganzoli, Angelo Di Leo, Luca Malorni	20
16	Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer 2019 ·Clinical Breast Cancer ·Lorenzo Rossi, Amelia McCartney, Emanuela Risi, Irene De Santo, Ilenia Migliaccio, Luca Malorni, Laura Biganzoli, Angelo Di Leo	11
17	Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancer 2019 ·The Breast ·Amelia McCartney, Matteo Benelli, Angelo Di Leo	1
18	Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT) 2019 ·European Journal of Cancer ·Amelia McCartney, Chiara Biagioni, Gaia Schiavon, Mattias Bergqvist, Karin Mattsson, Ilenia Migliaccio, Matteo Benelli, Dario Romagnoli, Martina Bonechi, Giulia Boccalini, Marta Pestrin, Francesca Galardi, Francesca De Luca, Laura Biganzoli, Martine Piccart, William J. Gradishar, Stephen Chia, Angelo Di Leo, Luca Malorni	25
19	Metabolomics in breast cancer: A decade in review 2018 ·Cancer Treatment Reviews ·Amelia McCartney, Alessia Vignoli, Laura Biganzoli, Richard R. Love, Leonardo Tenori, Claudio Luchinat, Angelo Di Leo	88
20	Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature 2018 ·Anticancer Research ·Lorenzo Rossi, Chiara Biagioni, Amelia McCartney, Erica Moretti, Marta Pestrin, Giuseppina Sanna, Emanuela Risi, Luca Malorni, Angelo Di Leo, Laura Biganzoli	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact